Anebulo Pharmaceuticals

(OTC) ANEB

Current Price$0.46

Market Cap$20.09M

Since IPO (2021)-93%

5 Year-93%

1 Year-54%

1 Month-18%

Anebulo Pharmaceuticals Financials at a Glance

Market Cap

$20.09M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.98M

EPS (TTM)

$-0.19

P/E Ratio

-2.54

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$0.46

Volume

3,209

Open

$0.52

Price

$0.46

Volume

3,209

Open

$0.52

Previous Close

$0.49

Daily Range

$0.46 - $0.52

52-Week Range

$0.30 - $3.42

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$0.46

Volume

3,209

Open

$0.52

Previous Close

$0.49

Daily Range

$0.46 - $0.52

52-Week Range

$0.30 - $3.42

ANEB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anebulo Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Richard Anthony Cunningham

Website

www.anebulo.com

Headquarters

Lakeway, TX 78734, US

ANEB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-70%

Return on Capital

-1%

Return on Assets

-85%

Earnings Yield

-39.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.09M

Shares Outstanding

40.78M

Volume

3.21K

Avg. Volume

42.24K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.22M

EBITDA

$8.10M

Operating Cash Flow

$6.35M

Capital Expenditure

$3.00

Free Cash Flow

$6.35M

Cash & ST Invst.

$11.63M

Total Debt

$0.00

Anebulo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$20.09M

N/A

Market Cap/Employee

$10.05M

N/A

Employees

N/A

Net Income

$2.00M

+18.8%

EBITDA

$2.62M

-9.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$9.04M

-39.7%

Accounts Receivable

$56.78K

+84.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-84.68%

N/A

Return on Invested Capital

-1.03%

N/A

Free Cash Flow

$1.31M

+6.6%

Operating Cash Flow

$1.31M

+6.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ESLAEstrella Immunopharma, Inc.

ESLAEstrella Immunopharma, Inc.$1.26+0.79%

OKYOOKYO Pharma Limited

OKYOOKYO Pharma Limited$1.65+1.23%

CLNNClene Inc.

CLNNClene Inc.$6.57-9.75%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.17+1.46%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.21-1.23%

TLSATiziana Life Sciences Ltd

TLSATiziana Life Sciences Ltd$1.53-3.16%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$3.69-7.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLATesla

TSLATesla$446.61+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.22+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.05-0.01%

SMRNuScale Power

SMRNuScale Power$13.58+0.08%

ODYSOdysight.ai

ODYSOdysight.ai$5.40+0.21%

DGXXDigi Power X

DGXXDigi Power X$7.62+0.15%

MARAMara Holdings

MARAMara Holdings$13.71+0.06%

Questions About ANEB

What is the current price of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals is trading at $0.46 per share.

What is the 52-week range for Anebulo Pharmaceuticals?

Over the past 52 weeks, Anebulo Pharmaceuticals has traded between $0.30 and $3.42.

How much debt does Anebulo Pharmaceuticals have?

As of the most recent reporting period, Anebulo Pharmaceuticals reported total debt of N/A.

How much cash does Anebulo Pharmaceuticals have on hand?

Anebulo Pharmaceuticals reported $9.04M in cash and cash equivalents in its most recent financial results.

What is Anebulo Pharmaceuticals’s dividend yield?

Anebulo Pharmaceuticals does not currently have a dividend yield.

Anebulo Pharmaceuticals

Anebulo Pharmaceuticals Financials at a Glance

ANEB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Anebulo Pharmaceuticals

ANEB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Anebulo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANEB

What is the current price of Anebulo Pharmaceuticals?

What is the 52-week range for Anebulo Pharmaceuticals?

How much debt does Anebulo Pharmaceuticals have?

How much cash does Anebulo Pharmaceuticals have on hand?

What is Anebulo Pharmaceuticals’s dividend yield?

Premium Investing Services